Whole Genome Sequencing Analysis
Complete analysis of human and non-human genomes with variant calling, annotation, and quality metrics. Supports both research and clinical-grade pipelines with customisable parameters.
From high-throughput sequencing analysis to custom bioinformatics development, CoveHub Forest CE provides the complete technology stack needed to advance your genomics research. Our platform-as-a-service approach delivers enterprise-grade capabilities with the flexibility to scale according to your project requirements.
View Pricing Plans →Our comprehensive suite of services covers every aspect of genomic data analysis, from raw sequencing data to actionable insights.
Complete analysis of human and non-human genomes with variant calling, annotation, and quality metrics. Supports both research and clinical-grade pipelines with customisable parameters.
Focused analysis of specific genomic regions with enhanced sensitivity for variant detection. Ideal for clinical diagnostics and targeted research applications.
Comprehensive RNA-seq analysis including differential expression, pathway analysis, and novel transcript discovery. Supports both bulk and single-cell RNA sequencing datasets.
Tailored algorithm development and pipeline customisation to meet specific research requirements. Our team develops bespoke solutions for unique analytical challenges.
Enterprise-grade data storage and management with full GDPR compliance. Includes automated backup systems, audit trails, and secure data sharing capabilities.
Comprehensive training programmes and expert consultation to maximise the value of your genomics investments. Includes platform training and bioinformatics education.
Flexible pricing options designed to support research institutions and organisations of all sizes.
Perfect for academic research groups and small biotechnology companies starting their genomics journey.
Comprehensive platform access for established research institutions and medium-sized biotechnology companies.
Tailored solutions for large research consortiums and pharmaceutical companies with extensive genomics programmes.